Retrotope
Pharmaceuticals, 4300 El Camino Real Ste 201, Los Altos, California, 94022, United States, 11-50 Employees
Phone Number: +16*********
Who is RETROTOPE
Retrotopes proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitocho...
Read More
-
Headquarters: 4300 El Camino Real Ste 201, Los Altos, California, 94022, United States
-
Date Founded: 2006
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 621511 |
Show More
Retrotope Org Chart and Mapping
Email
Phone
Similar Companies to Retrotope
BioAge Labs
-
51-200
-
$ 1 Million to 5 Million
BridgeBio
-
201-500
-
$ 50 Million to 100 Million
CARGO Therapeutics
-
11-50
-
$ Under 1 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Retrotope
Answer: Retrotope's headquarters are located at 4300 El Camino Real Ste 201, Los Altos, California, 94022, United States
Answer: Retrotope's phone number is +16*********
Answer: Retrotope's official website is https://retrotope.com
Answer: Retrotope's revenue is $1 Million to $5 Million
Answer: Retrotope's SIC: 2834
Answer: Retrotope's NAICS: 621511
Answer: Retrotope has 11-50 employees
Answer: Retrotope is in Pharmaceuticals
Answer: Retrotope top competitors include: BioAge Labs , BridgeBio , CARGO Therapeutics
Answer: Retrotope contact info: Phone number: +16********* Website: https://retrotope.com
Answer: Retrotopes proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitochondrial membranes and neurodegeneration in Parkinsons, Alzheimers, Friedreichs ataxia and other diseases. Retrotopes first drug candidate, RT001, confers cell protection against oxidative stress in high energy tissues like brain, retina and heart tissue by inhibiting mitochondrial lipid peroxidation. Its mechanism of action has been shown not only to prevent further cellular damage but also to recover mitochondrial function. RT001s molecular structure is so similar to ordinary fats that the body naturally distributes them throughout the tissues wherever they are needed. The drug has been determined safe in human trials in a recent Phase 1/2 clinical trial in Friedreichs ataxia patients. Retrotope is a privately held company founded and backed by worldrenowned scientists, entrepreneurs, and investors. The company founders have dozens of years of experience in drug discovery technologies, a member of the US National Academy of Sciences, and several successful startups among them. Retrotope has developed its science virtually, with over 50 collaborations at major centers of excellence around the world that have yielded insights into the mechanisms of several diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month